Original Papers- MORIMOTO Ryo -
number of results to view: what to display: sort:
total:64
[2018]
1.Effects of surgical treatment for acromegaly on knee MRI structural features..[Endocrine journal,65(10),(2018),991-999]Masahiro Nezu, Masataka Kudo, Ryo Morimoto, Yoshikiyo Ono, Kei Omata, Yuta Tezuka, Yasuhiro Igarashi, Shin Hitachi, Kei Takase, Sadayoshi Ito, Fumitoshi Satoh
10.1507/endocrj.EJ18-0108
http://www.ncbi.nlm.nih.gov/pubmed/30012912
2.Tumor microenvironment in functional adrenocortical adenomas: immune cell infiltration in cortisol-producing adrenocortical adenoma..[Human pathology,77,(2018),88-97]Yuko Kitawaki, Yasuhiro Nakamura, Fumie Kubota-Nakayama, Yuto Yamazaki, Yasuhiro Miki, Shuko Hata, Kazue Ise, Kumi Kikuchi, Ryo Morimoto, Fumitoshi Satoh, Hironobu Sasano
10.1016/j.humpath.2018.03.016
http://www.ncbi.nlm.nih.gov/pubmed/29596893
3.Progress in the Management of Primary Aldosteronism..[American journal of hypertension,31(5),(2018),522-531]Ryo Morimoto, Kei Omata, Sadayoshi Ito, Fumitoshi Satoh
10.1093/ajh/hpy018
http://www.ncbi.nlm.nih.gov/pubmed/29534182
4.Image quality and radiation dose of low-tube-voltage CT with reduced contrast media for right adrenal vein imaging..[European journal of radiology,98,(2018),150-157]Yuki Takahashi, Hideki Ota, Kensuke Omura, Yutaka Dendo, Katharina Otani, Tomonori Matsuura, Masahiro Kitami, Kazumasa Seiji, Yuta Tezuka, Masahiro Nezu, Yoshikiyo Ono, Ryo Morimoto, Fumitoshi Satoh, Kei Takase
10.1016/j.ejrad.2017.11.017
http://www.ncbi.nlm.nih.gov/pubmed/29279155
[2017]
5.Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism.[JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM,102(4),(2017),1182-1192]Yuto Yamazaki, Yasuhiro Nakamura, Kei Omata, Kazue Ise, Yuta Tezuka, Yoshikiyo Ono, Ryo Morimoto, Yukinaga Nozawa, Celso E. Gomez-Sanchez, Scott A. Tomlins, William E. Rainey, Sadayoshi Ito, Fumitoshi Satoh, Hironobu Sasano
10.1210/jc.2016-2986
http://www.ncbi.nlm.nih.gov/pubmed/28388725 http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000402195300010&DestApp=WOS
6.Anatomical Variations of the Right Adrenal Vein: Concordance Between Multidetector Computed Tomography and Catheter Venography..[Hypertension,69(3),(2017),428-434]Omura K, Ota H, Takahashi Y, Matsuura T, Seiji K, Arai Y, Morimoto R, Satoh F, Takase K
7.Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patient..[J Dermatol,(2017)]Fujimura T, Kambayashi Y, Furudate S, Kakizaki A, Hidaka T, Haga T, Hashimoto A, Morimoto R, Aiba S
8.Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort..[Lancet Diabetes Endocrinol,(2017)]Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, Satoh F, Amar L, Quinkler M, Deinum J, Beuschlein F, Kitamoto KK, Pham U, Morimoto R, Umakoshi H, Prejbisz A, Kocjan T, Naruse M, Stowasser M, Nishikawa T, Young WF Jr, Gomez-Sanchez CE, Funder JW, Reincke M; Primary Aldosteronism Surgery Outcome (PASO) investigators
9.Rapid screening of primary aldosteronism by a novel chemiluminescent immunoassay..[Hypertension,(2017)]Morimoto R, Ono Y, Tezuka Y, Kudo M, Yamamoto S, Arai T, Gomez- Sanchez CE, Sasano H, Ito S, Satoh F
10.Phase I study of nivolumab combined with IFN-β for patients with advanced melanoma..[Oncotarget,(2017)]Fujimura T, Hidaka T, Kambayashi Y, Furudate S, Kakizaki A, Tono H, Tsukada A, Haga T, Hashimoto A, Morimoto R, Yamaguchi T, Takano T, Aiba S
[2016]
11.Expression of steroidogenic enzymes and their transcription factors in cortisol-producing adrenocortical adenomas: immunohistochemical analysis and quantitative RT-PCR studies..[Hum Pathol,54,(2016),165-173]Kubota-Nakayama F, Nakamura Y, Konosu-Fukaya S, Azmahani A, Ise K, Yamazaki Y, Kitawaki Y, Felizola SJ, Ono Y, Omata K, Morimoto R, Iwama N, Satoh F, Sasano H
12.Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis..[Hum Pathol,53,(2016),41-50]Yamazaki Y, Nakamura Y, Shibahara Y, Konosu-Fukaya S, Sato N, Kubota F, Oki Y, Baba S, Midorikawa S, Morimoto R, Satoh F, Sasano H
13.Renal Resistive Index Predicts Postoperative Blood Pressure Outcome in Primary Aldosteronism..[Hypertension,67(3),(2016),654-660]Iwakura Y, Ito S, Morimoto R, Kudo M, Ono Y, Nezu M, Takase K, Seiji K, Ishidoya S, Arai Y, Funamizu Y, Miki T, Nakamura Y, Sasano H, Satoh F
14.Intratumoral heterogeneity of steroidogenesis in aldosterone-producing adenoma revealed by intensive double- and triple-immunostaining for CYP11B2/B1 and CYP17..[Mol Cell Endocrinol,422,(2016),57-63]Nakamura Y, Kitada M, Satoh F, Maekawa T, Morimoto R, Yamazaki Y, Ise K, Gomez-Sanchez CE, Ito S, Arai Y, Dezawa M, Sasano H
15.Clinical Management and Outcomes of Adrenal Hemorrhage Following Adrenal Vein Sampling in Primary Aldosteronism..[Hypertension,67(1),(2016),146-152]Monticone S, Satoh F, Dietz AS, Goupil R, Lang K, Pizzolo F, Gordon RD, Morimoto R, Reincke M, Stowasser M, Mulatero P
16.A case of bilateral aldosterone-producing adenomas differentiated by segmental adrenal venous sampling for bilateral adrenal sparing surgery..[J Hum Hypertens,30(6),(2016),379-385]Morimoto R, Satani N, Iwakura Y, Ono Y, Kudo M, Nezu M, Omata K, Tezuka Y, Seiji K, Ota H, Kawasaki Y, Ishidoya S, Nakamura Y, Arai Y, Takase K, Sasano H, Ito S, Satoh F
17.Intra-adrenal Aldosterone Secretion: Segmental Adrenal Venous Sampling for Localization..[Radiology,278(1),(2016),265-274]Satani N, Ota H, Seiji K, Morimoto R, Kudo M, Iwakura Y, Ono Y, Nezu M, Omata K, Ito S, Satoh F, Takase K
18.Dynamic multidetector CT and non-contrast-enhanced MR for right adrenal vein imaging: comparison with catheter venography in adrenal venous sampling..[Eur Radiol,26(3),(2016),622-630]Ota H, Seiji K, Kawabata M, Satani N, Omata K, Ono Y, Iwakura Y, Morimoto R, Matsuura T, Kudo M, Tominaga J, Satoh F, Ito S, Takase K
19.Pancreatic solitary fibrous tumor causing ectopic adrenocorticotropic hormone syndrome..[Mol Cell Endocrinol,436,(2016),268-273]Murakami K, Nakamura Y, Felizola SJ, Morimoto R, Satoh F, Takanami K, Katakami H, Hirota S, Takeda Y, Meguro-Horike M, Horike SI, Unno M, Sasano H
20.Histopathological classification of cross-sectional image negative hyperaldosteronism..[J Clin Endocrinol Metab,(2016)]Yamazaki Y, Nakamura Y, Omata K, Ise K, Tezuka Y, Ono Y, Morimoto R, Nozawa Y, Gomez-Sanchez CE, Tomlins SA, Rainey WE, Ito S, Satoh F, Sasano H
Page: [1] [2] [3] [4] [next]
BackTop
copyright(c)2005 Tohoku University